Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Directing Proteins to the Rough Endoplasmic Reticulum

Directing Proteins to the Rough Endoplasmic Reticulum

The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...

Structural Protein Function

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to form...

Structural Protein Function

Structural Protein Function

Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to form...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Structural evidence that RNA contributes to polymorphism of tau amyloid fibrils.

iScience·2026

Same author

In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils.

ACS chemical neuroscience·2026

Same author

Genetic and structural aspects of amyloid diseases.

Science translational medicine·2025

Same author

Leveraging bioorthogonal conjugation for alpha synuclein fibril surveillance.

bioRxiv : the preprint server for biology·2025

Same author

Structural basis for L-isoaspartyl-containing protein recognition by the human PCMTD1 cullin-RING E3 ubiquitin ligase.

The Journal of biological chemistry·2025

Same author

Structural basis of heme scavenging by the ChtA and HtaA hemophores in Corynebacterium diphtheriae.

The Journal of biological chemistry·2025

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Published on: April 1, 2016

Directed evolution and structural characterization of a simvastatin synthase.

Xue Gao¹, Xinkai Xie, Inna Pashkov

¹Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Chemistry & Biology

|October 31, 2009

Summary

Directed evolution enhanced the enzyme LovD for improved simvastatin production. Structural analysis revealed mutations stabilized the enzyme for better catalysis, increasing efficiency 11-fold in an E. coli platform.

More Related Videos

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

Published on: March 25, 2020

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

Related Experiment Videos

Last Updated: Jun 19, 2026

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Directed Evolution Method in Saccharomyces cerevisiae: Mutant Library Creation and Screening

Published on: April 1, 2016

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

Published on: March 25, 2020

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

Area of Science:

Biocatalysis
Enzyme Engineering
Structural Biology

Background:

Enzymes from natural product pathways are valuable for semisynthetic pharmaceuticals.
LovD acyltransferase converts monacolin J acid (MJA) to lovastatin and can synthesize simvastatin with suboptimal efficiency.

Purpose of the Study:

Improve LovD properties for efficient simvastatin semisynthesis.
Understand the structural basis of improved LovD function.

Main Methods:

Directed evolution was employed to generate improved LovD variants.
Seven X-ray crystal structures were determined for LovD and its mutants.
An Escherichia coli-based biocatalytic platform was used for evaluation.

Main Results:

Mutants with enhanced catalytic efficiency, solubility, and thermal stability were obtained.
The best mutant showed an 11-fold increase in simvastatin production.
Structural comparisons revealed beneficial mutations stabilize a compact, catalytically favorable conformation.

Conclusions:

Directed evolution successfully improved LovD for simvastatin semisynthesis.
Structural insights explain the enhanced catalytic performance of LovD mutants.
Engineered LovD offers a more efficient biocatalyst for pharmaceutical production.